Suppression of cough by Emblica officinalis extract, dextromethorphan versus placebo during endobronchial ultrasound bronchoscopy: a randomized double blind, double dummy, placebo-controlled trial

W. Boonfueang (Bangkok, Thailand), T. Sriprasart (Bangkok, Thailand)

Source: Virtual Congress 2021 – Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Boonfueang (Bangkok, Thailand), T. Sriprasart (Bangkok, Thailand). Suppression of cough by Emblica officinalis extract, dextromethorphan versus placebo during endobronchial ultrasound bronchoscopy: a randomized double blind, double dummy, placebo-controlled trial. 2453

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of borago extract on moderate persistent asthma, a phase two randomized, double blind placebo-controlled clinical trial
Source: International Congress 2016 – Asthma management
Year: 2016


Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008


Propofol versus the combination propofol/hydrocodone sedation in flexible bronchoscopy – A randomized, placebo-controlled, double-blind study
Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy
Year: 2010

A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009

The efficacy and safety of topical phenylephrine before flexible bronchoscopy: a double-blind, randomized controlled trial
Source: Annual Congress 2008 - News from diagnostic bronchoscopy
Year: 2008


A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009

A single centre, double blind, double dummy, placebo controlled, randomized, three period cross-over phase III trial to demonstrate therapeutic equivalence between a generic and branded inhalation product of ipratropium bromide in subjects with
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

Utility of anticholinergic premedication for bronchoscopy: a randomized controlled trial
Source: Eur Respir J 2005; 26: Suppl. 49, 531s
Year: 2005

Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017


Propofol sedation for flexible bronchoscopy: A large randomized, controlled, non-inferiority trial
Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy
Year: 2012

Effect of oral beta-alanine supplementation on muscle carnosine in patients with COPD: A double blind, placebo-controlled, randomized trial
Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Year: 2020




Chinese herbs in treatment of postinfectious cough: A multi-centre, randomized, double-blind, placebo-controlled trial
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

A multicentre, double-blind, double-dummy, randomized, parallel group study to assess efficacy and safety of beclomethasone dipropionate and ease of handling of a breath operated aerosol inhaler in adults with reversible airways obstruction
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Effect of salmetrol-fluticason combination and tiotropium on clinical and physiological improvement of bronchial anthracofibrosis, a double blind randomized, cross over, placebo controlled, clinical trial.
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017


Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009


Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo-controlled, double blind, multicenter study with 52-week follow up
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011

Chinese herbs in treatment of influenza: A multi-centre, randomized, double-blind, placebo-controlled trial
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010



Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
Source: ERJ Open Res, 6 (4) 00132-2020; 10.1183/23120541.00132-2020
Year: 2020



Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010